NVision Imaging Technologies Company
NVision has developed a platform which polarizes natural metabolites, enabling these safe molecules to be used as an agent for imaging tumor metabolism via MRI. The company's technology uses quantum physics advances to disrupt the medical imaging and diagnostics space by allowing standard Magnetic Resonance Spectrometers to assess human metabolism, allowing healthcare professionals to perform advanced cancer diagnosis and real-time monitoring of response to therapy.
Founded Date:
2015-01-01
Last Funding Date:
2025-01-01
Employee Number:
101-250
Headquarters:
Ulm,Baden-Wurttemberg,Germany,Europe
Total Funding:
100241099
Funding Status:
private
Industry:
Thermometry
Super Industry:
Quantum Sensing
Funding Stage:
Early Stage Venture
Funding Total Value:
100241099
Last Funding Total Usd:
1529979
Last Funding Total Currency:
USD
Last Funding Total Value:
1529979
Founders:
Alex Retzker,Fedor Jelezko,Ilai Schwartz,Martin Plenio,Sella Brosh